Todd R. Palmby

Medicine · Health Sciences

25h-index3.6kcitations30works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HER2/EGFR in Cancer Research(6), Advanced Breast Cancer Therapies(6), Protein Kinase Regulation and GTPase Signaling(5), PARP inhibition in cancer therapy(4), Cell death mechanisms and regulation(3)

Publications30 total

Decoding kinase-adverse event associations for small molecule kinase inhibitors
Nature Communications·2022· 15 citedOpen Access
Critical Role of the Pleckstrin Homology and Cysteine-rich Domains in Vav Signaling and Transforming Activity
UNC Libraries·2021Open Access
FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy
Clinical Cancer Research·2018· 125 cited
U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
Clinical Cancer Research·2018· 96 citedOpen Access
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Advanced or Metastatic Breast Cancer
Clinical Cancer Research·2018· 106 cited
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer
Clinical Cancer Research·2017· 158 cited
FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy
The Oncologist·2017· 133 citedOpen Access
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma
Clinical Cancer Research·2016· 51 cited
21st Century Cardio-Oncology
JACC Basic to Translational Science·2016· 41 citedOpen Access
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
Clinical Cancer Research·2016· 137 cited
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs
Clinical Cancer Research·2016· 77 cited
Nonclinical Evaluations of Small-Molecule Oncology Drugs: Integration into Clinical Dose Optimization and Toxicity Management
Clinical Cancer Research·2016· 10 citedOpen Access
FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer
Clinical Cancer Research·2015· 365 cited
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline <i>BRCA</i>-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Clinical Cancer Research·2015· 509 cited
FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
Clinical Cancer Research·2014· 337 cited
Targeted therapy approvals: Summary and future directions.
Journal of Clinical Oncology·2014
Radium Ra 223 Dichloride Injection: U.S. Food and Drug Administration Drug Approval Summary
Clinical Cancer Research·2013· 162 cited
Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval Summary
Clinical Cancer Research·2013· 60 cited
Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary
Clinical Cancer Research·2013· 65 cited
U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma
Clinical Cancer Research·2013· 240 cited
page 1 of 2Next →

Frequent Co-authors

Richard Pazdur(18), Rajeshwari Sridhara(14), Shenghui Tang(13), Amna Ibrahim(12), Geoffrey Kim(8), Julia A. Beaver(8), Paul G. Kluetz(7), William F. Pierce(7), Qi Liu(6), Laleh Amiri‐Kordestani(6), Jingyu Yu(6), Xiaohong Chen(6), Gideon M. Blumenthal(5), Robert Justice(5), Channing J. Der(5), Amy E. McKee(4), Rosane Charlab(4), Amy Tilley(4), Jeanne Fourie Zirkelbach(4), V. Ellen Maher(4)